Along with PARP14, PARP15 is also overexpressed in B-cell lymphoma [83]; although efforts have been made to develop more selective inhibitors targeting PARP15, the effect of its inhibition on tumor progression has not yet been described [19,32]. Here, PARP15 is linked to neoplasm.